Measuring Radiation Dose in Prostate Cancer Patients' Lymphocytes
Author Information
Author(s): Felix Zwicker, Benedict Swartman, Florian Sterzing, Gerald Major, Klaus-Josef Weber, Peter E Huber, Christian Thieke, Jürgen Debus, Klaus Herfarth
Primary Institution: Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
Hypothesis
Can in-vivo measurements of dose distribution in lymphocytes provide insights into the effectiveness of different radiation techniques for prostate cancer?
Conclusion
The study found that Step-and-Shoot-IMRT exposes fewer lymphocytes to middle doses compared to 3D conformal radiotherapy, while high-dose exposure is similar for both techniques.
Supporting Evidence
- The study measured gamma-H2AX foci in lymphocytes to assess radiation exposure.
- Results indicated that SSIMRT leads to fewer lymphocytes receiving middle doses compared to 3D.
- The method allows for in-vivo estimation of dose distribution without invasive procedures.
Takeaway
Doctors can check how much radiation patients' blood cells get during prostate cancer treatment to make sure they are not getting too much radiation in healthy areas.
Methodology
Blood samples were taken from 20 patients before and after radiation, and gamma-H2AX foci were counted in lymphocytes to assess dose distribution.
Potential Biases
Potential inaccuracies in dose measurement due to lymphocyte movement and repeated exposure during treatment.
Limitations
The study's findings may not be fully applicable due to the circulation of lymphocytes during irradiation.
Participant Demographics
All participants were male, with a median age of 71.4 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website